Indeed, Leclerc et al. demonstrated that NRP1 interacts with SEMA 3A by inhibiting the migration of cytotoxic LT CD8+ within the tumor and inhibiting their tumor cell lysis function (135). This evidence concerns the gene CD8A and neoplasm.